247 related articles for article (PubMed ID: 36987712)
1. H4C5 missense variant leads to a neurodevelopmental phenotype overlapping with Angelman syndrome.
Borja N; Borjas-Mendoza P; Bivona S; Peart L; Gonzalez J; Johnson BK; Guo S; Yusupov R; ; Bademci G; Tekin M
Am J Med Genet A; 2023 Jul; 191(7):1911-1916. PubMed ID: 36987712
[TBL] [Abstract][Full Text] [Related]
2. Blended phenotype of combination of HERC2 and AP3B2 deficiency and Angelman syndrome caused by paternal isodisomy of chromosome 15.
Ueda K; Ogawa S; Matsuda K; Hasegawa Y; Nishi E; Yanagi K; Kaname T; Yamamoto T; Okamoto N
Am J Med Genet A; 2021 Oct; 185(10):3092-3098. PubMed ID: 34042275
[TBL] [Abstract][Full Text] [Related]
3. De novo MCM6 variants in neurodevelopmental disorders: a recognizable phenotype related to zinc binding residues.
Smits DJ; Schot R; Popescu CA; Dias KR; Ades L; Briere LC; Sweetser DA; Kushima I; Aleksic B; Khan S; Karageorgou V; Ordonez N; Sleutels FJGT; van der Kaay DCM; Van Mol C; Van Esch H; Bertoli-Avella AM; Roscioli T; Mancini GMS
Hum Genet; 2023 Jul; 142(7):949-964. PubMed ID: 37198333
[TBL] [Abstract][Full Text] [Related]
4. A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay.
Schoch K; Meng L; Szelinger S; Bearden DR; Stray-Pedersen A; Busk OL; Stong N; Liston E; Cohn RD; Scaglia F; Rosenfeld JA; Tarpinian J; Skraban CM; Deardorff MA; Friedman JN; Akdemir ZC; Walley N; Mikati MA; Kranz PG; Jasien J; McConkie-Rosell A; McDonald M; Wechsler SB; Freemark M; Kansagra S; Freedman S; Bali D; Millan F; Bale S; Nelson SF; Lee H; Dorrani N; ; ; Goldstein DB; Xiao R; Yang Y; Posey JE; Martinez-Agosto JA; Lupski JR; Wangler MF; Shashi V
Am J Hum Genet; 2017 Feb; 100(2):343-351. PubMed ID: 28132692
[TBL] [Abstract][Full Text] [Related]
5. Recurrent de novo missense variants across multiple histone H4 genes underlie a neurodevelopmental syndrome.
Tessadori F; Duran K; Knapp K; Fellner M; ; Smithson S; Beleza Meireles A; Elting MW; Waisfisz Q; O'Donnell-Luria A; Nowak C; Douglas J; Ronan A; Brunet T; Kotzaeridou U; Svihovec S; Saenz MS; Thiffault I; Del Viso F; Devine P; Rego S; Tenney J; van Haeringen A; Ruivenkamp CAL; Koene S; Robertson SP; Deshpande C; Pfundt R; Verbeek N; van de Kamp JM; Weiss JMM; Ruiz A; Gabau E; Banne E; Pepler A; Bottani A; Laurent S; Guipponi M; Bijlsma E; Bruel AL; Sorlin A; Willis M; Powis Z; Smol T; Vincent-Delorme C; Baralle D; Colin E; Revencu N; Calpena E; Wilkie AOM; Chopra M; Cormier-Daire V; Keren B; Afenjar A; Niceta M; Terracciano A; Specchio N; Tartaglia M; Rio M; Barcia G; Rondeau S; Colson C; Bakkers J; Mace PD; Bicknell LS; van Haaften G
Am J Hum Genet; 2022 Apr; 109(4):750-758. PubMed ID: 35202563
[TBL] [Abstract][Full Text] [Related]
6. De Novo Variants in SPOP Cause Two Clinically Distinct Neurodevelopmental Disorders.
Nabais Sá MJ; El Tekle G; de Brouwer APM; Sawyer SL; Del Gaudio D; Parker MJ; Kanani F; van den Boogaard MH; van Gassen K; Van Allen MI; Wierenga K; Purcarin G; Elias ER; Begtrup A; Keller-Ramey J; Bernasocchi T; van de Wiel L; Gilissen C; Venselaar H; Pfundt R; Vissers LELM; Theurillat JP; de Vries BBA
Am J Hum Genet; 2020 Mar; 106(3):405-411. PubMed ID: 32109420
[TBL] [Abstract][Full Text] [Related]
7. Expanding the phenotype of intellectual disability caused by HIVEP2 variants.
Goldsmith H; Wells A; Sá MJN; Williams M; Heussler H; Buckman M; Pfundt R; de Vries BBA; Goel H
Am J Med Genet A; 2019 Sep; 179(9):1872-1877. PubMed ID: 31207095
[TBL] [Abstract][Full Text] [Related]
8. De Novo Variants in the F-Box Protein FBXO11 in 20 Individuals with a Variable Neurodevelopmental Disorder.
Gregor A; Sadleir LG; Asadollahi R; Azzarello-Burri S; Battaglia A; Ousager LB; Boonsawat P; Bruel AL; Buchert R; Calpena E; Cogné B; Dallapiccola B; Distelmaier F; Elmslie F; Faivre L; Haack TB; Harrison V; Henderson A; Hunt D; Isidor B; Joset P; Kumada S; Lachmeijer AMA; Lees M; Lynch SA; Martinez F; Matsumoto N; McDougall C; Mefford HC; Miyake N; Myers CT; Moutton S; Nesbitt A; Novelli A; Orellana C; Rauch A; Rosello M; Saida K; Santani AB; Sarkar A; Scheffer IE; Shinawi M; Steindl K; Symonds JD; Zackai EH; ; ; Reis A; Sticht H; Zweier C
Am J Hum Genet; 2018 Aug; 103(2):305-316. PubMed ID: 30057029
[TBL] [Abstract][Full Text] [Related]
9. Further supporting SMARCC2-related neurodevelopmental disorder through exome analysis and reanalysis in two patients.
Li D; Downes H; Hou C; Hakonarson H; Zackai EH; Schrier Vergano SA; Bhoj EJ
Am J Med Genet A; 2022 Mar; 188(3):878-882. PubMed ID: 34881817
[TBL] [Abstract][Full Text] [Related]
10. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.
Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J
Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086
[TBL] [Abstract][Full Text] [Related]
11. A de novo variant in the human HIST1H4J gene causes a syndrome analogous to the HIST1H4C-associated neurodevelopmental disorder.
Tessadori F; Rehman AU; Giltay JC; Xia F; Streff H; Duran K; Bakkers J; Lalani SR; van Haaften G
Eur J Hum Genet; 2020 May; 28(5):674-678. PubMed ID: 31804630
[TBL] [Abstract][Full Text] [Related]
12. Trio exome sequencing identified a novel de novo WASF1 missense variant leading to recurrent site substitution in a Chinese patient with developmental delay, microcephaly, and early-onset seizures: A mutational hotspot p.Trp161 and literature review.
Zhao A; Zhou R; Gu Q; Liu M; Zhang B; Huang J; Yang B; Yao R; Wang J; Lv H; Wang J; Shen Y; Wang H; Chen X
Clin Chim Acta; 2021 Dec; 523():10-18. PubMed ID: 34478686
[TBL] [Abstract][Full Text] [Related]
13. Recurrent
Tan NB; Pagnamenta AT; Ferla MP; Gadian J; Chung BH; Chan MC; Fung JL; Cook E; Guter S; Boschann F; Heinen A; Schallner J; Mignot C; Keren B; Whalen S; Sarret C; Mittag D; Demmer L; Stapleton R; Saida K; Matsumoto N; Miyake N; Sheffer R; Mor-Shaked H; Barnett CP; Byrne AB; Scott HS; Kraus A; Cappuccio G; Brunetti-Pierri N; Iorio R; Di Dato F; Pais LS; Yeung A; Tan TY; Taylor JC; Christodoulou J; White SM
J Med Genet; 2022 May; 59(5):511-516. PubMed ID: 34183358
[TBL] [Abstract][Full Text] [Related]
14. Variant recurrence in neurodevelopmental disorders: the use of publicly available genomic data identifies clinically relevant pathogenic missense variants.
Lecoquierre F; Duffourd Y; Vitobello A; Bruel AL; Urteaga B; Coubes C; Garret P; Nambot S; Chevarin M; Jouan T; Moutton S; ; Tran-Mau-Them F; Philippe C; Sorlin A; Faivre L; Thauvin-Robinet C
Genet Med; 2019 Nov; 21(11):2504-2511. PubMed ID: 31036916
[TBL] [Abstract][Full Text] [Related]
15. De novo ARHGEF9 missense variants associated with neurodevelopmental disorder in females: expanding the genotypic and phenotypic spectrum of ARHGEF9 disease in females.
Scala M; Zonneveld-Huijssoon E; Brienza M; Mecarelli O; van der Hout AH; Zambrelli E; Turner K; Zara F; Peron A; Vignoli A; Striano P
Neurogenetics; 2021 Mar; 22(1):87-94. PubMed ID: 32939676
[TBL] [Abstract][Full Text] [Related]
16. PUF60 variants cause a syndrome of ID, short stature, microcephaly, coloboma, craniofacial, cardiac, renal and spinal features.
Low KJ; Ansari M; Abou Jamra R; Clarke A; El Chehadeh S; FitzPatrick DR; Greenslade M; Henderson A; Hurst J; Keller K; Kuentz P; Prescott T; Roessler F; Selmer KK; Schneider MC; Stewart F; Tatton-Brown K; Thevenon J; Vigeland MD; Vogt J; Willems M; Zonana J; Study DD; Smithson SF
Eur J Hum Genet; 2017 May; 25(5):552-559. PubMed ID: 28327570
[TBL] [Abstract][Full Text] [Related]
17. De novo variants in CNOT9 cause a neurodevelopmental disorder with or without epilepsy.
von Wintzingerode L; Ben-Zeev B; Cesario C; Chan KM; Depienne C; Elpeleg O; Iascone M; Kelley WV; Nassogne MC; Niceta M; Pezzani L; Rahner N; Revencu N; Bekheirnia MR; Santiago-Sim T; Tartaglia M; Thompson ML; Trivisano M; Hentschel J; Sticht H; Abou Jamra R; Oppermann H
Genet Med; 2023 Jul; 25(7):100859. PubMed ID: 37092538
[TBL] [Abstract][Full Text] [Related]
18. Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism.
Zahra Q; Çakmak Ç; Koprulu M; Shuaib M; Sobreira N; Kalsner L; Sobreira J; Guillen Sacoto MJ; Malik S; Tolun A
J Hum Genet; 2020 Dec; 65(12):1115-1123. PubMed ID: 32737394
[TBL] [Abstract][Full Text] [Related]
19. Angelman syndrome and severe infections in a patient with de novo 15q11.2-q13.1 deletion and maternally inherited 2q21.3 microdeletion.
Neubert G; von Au K; Drossel K; Tzschach A; Horn D; Nickel R; Kaindl AM
Gene; 2013 Jan; 512(2):453-5. PubMed ID: 23124039
[TBL] [Abstract][Full Text] [Related]
20. De novo heterozygous missense and loss-of-function variants in CDC42BPB are associated with a neurodevelopmental phenotype.
Chilton I; Okur V; Vitiello G; Selicorni A; Mariani M; Goldenberg A; Husson T; Campion D; Lichtenbelt KD; van Gassen K; Steinraths M; Rice J; Roeder ER; Littlejohn RO; Srour M; Sebire G; Accogli A; Héron D; Heide S; Nava C; Depienne C; Larson A; Niyazov D; Azage M; Hoganson G; Burton J; Rush ET; Jenkins JL; Saunders CJ; Thiffault I; Alaimo JT; Fleischer J; Groepper D; Gripp KW; Chung WK
Am J Med Genet A; 2020 May; 182(5):962-973. PubMed ID: 32031333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
